<- Back to digest

Arthroscopy - 2026-10-08 - Journal Article; Review

Biologic Graft Augmentation Is Associated With Lower Retear Rates and Greater Tendon Thickness Compared With Arthroscopic Rotator Cuff Repair Without Augmentation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Amin V, Ghayyad K, Oshikoya O, Goltz D, Huffman GR

meta-analysisLOE IIn = 9 studies, 556 patientsMinimum 1 year required for inclusion; specific mean not reported.

Topics

sportsshoulder elbow
PMID: 42850980DOI: 10.1002/arj.70619View on PubMed ->

Key Takeaway

Biologic graft augmentation in arthroscopic rotator cuff repair reduces retear rates by 69% (risk ratio 0.31) compared with repair alone across 9 RCTs.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This systematic review and meta-analysis of 9 RCTs evaluated biologic graft augmentation versus standard arthroscopic rotator cuff repair. Augmentation produced a significant reduction in retear rate (RR 0.31, 95% CI 0.22–0.45, P<0.00001) and a 1.20 mm increase in tendon thickness at final follow-up (P<0.00001). ASES and Constant scores improved significantly with augmentation, but UCLA scores did not reach significance, and heterogeneity in graft type limits interpretation.

Key Limitation

The small aggregate sample size (n=556 across 9 trials) combined with heterogeneity in graft type, tear size, and repair technique limits the ability to identify which specific biologic augment drives the observed benefit.

Original Abstract

PURPOSE

To perform a systematic review and meta-analysis of Level I and II randomized studies evaluating biologic graft augmentation in arthroscopic or arthroscopic-equivalent rotator cuff repair.

METHODS

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic literature search was conducted in PubMed, Scopus, Embase, and Cochrane databases. Randomized controlled trials comparing the use of a biologic graft augmentation in adjunct to standard arthroscopic repair were included. A minimum clinical follow-up of greater than 1 year was required for inclusion. Outcome measures included retear rate, tendon thickness, American Shoulder and Elbow Surgeons score, Constant score, and the University of California Los Angeles score. Random-effects models were used to calculate mean differences and 95% confidence intervals.

RESULTS

From our literature search, 9 randomized controlled trials consisting of 556 patients met criteria for inclusion in the meta-analysis. The use of biologic graft augmentation showed a significant reduction in retear rates (risk ratio = 0.31; confidence interval: [0.22, 0.45]; P < .00001) and a significant increase in tendon thickness at final follow-up (mean difference: 1.20 mm; confidence interval [1.14, 1.26]; P < .00001). Meta-analysis also revealed a significant increase between preoperative and postoperative American Shoulder and Elbow Surgeons and Constant score and a nonsignificant increase between preoperative and postoperative University of California Los Angeles score.

CONCLUSIONS

Biologic graft augmentation in arthroscopic or arthroscopic-equivalent rotator cuff repair was associated with lower retear rates and greater tendon thickness. Clinical outcome improvement was less consistent across reported patient-reported measures, and interpretation should account for heterogeneity in graft type and outcome reporting.

LEVEL OF EVIDENCE

Level II, systematic review and meta-analysis of Level I and II studies.